Growing Number Of Pet Owners Boosts Veterinary API Manufacturing Market: A Leading Driver Behind Veterinary Active Pharmaceutical Ingredients Manufacturing Market Expansion in 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Will the Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Market Size Be by 2025?
The market size for manufacturing veterinary active pharmaceutical ingredients has seen considerable growth in the past few years. It is anticipated to expand from $7.46 billion in 2024 to $8.05 billion in 2025, with a compound annual growth rate (CAGR) of 7.9%. The historical growth can be credited to factors such as the increase in pet ownership, strict regulatory norms, enhanced emphasis on animal nutrition, investment in research and development, and global economic progression.

What's the Long-Term Growth Forecast for the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Through 2029?
Expectations are high for the veterinary active pharmaceutical ingredients manufacturing market to experience significant growth over the next several years, with projections indicating it will reach a value of $11.19 billion in 2029 at a CAGR of 8.6%. This anticipated increase during the forecast period can be attributed to factors such as the rise in personalized veterinary medicine, market expansion due to globalization, a concentration on regulatory compliance, the growing significance of animal welfare, and advances in drug delivery systems. The forecast period will also likely see rising demand for nutraceuticals. Major shifts forecasted for the period include technological progress in manufacturing methods, a growing trend of outsourcing API manufacturing, a move towards biotechnology-based APIs, and an increase in digitalization and automation in manufacturing. The veterinary API market is also expected to globalize further.

View the full report here:
https://www.thebusinessresearchcompany.com/report/veterinary-active-pharmaceutical-ingredients-manufacturing-global-market-report

What Are the Key Growth Drivers Fueling the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Expansion?
The veterinary active pharmaceutical ingredients manufacturing market is poised for growth, largely driven by the rise in pet ownership. Pet owners, whether they have purchased or adopted an animal companion, demand certain veterinary medications to ensure their pets' health, thereby driving the industry. As noted by Animal Medicines Australia, a non-profit organisation, there was a marked rise in pet ownership in Australia in 2022. The figures suggest an increase to 28,730.8 pet owners, a significant jump from 39% in 2021, reflecting a 24% uptick. This suggests a clear trend of increasing pet adoption and spending on their care. The trend of growing pet ownership in Australia serves to underscore the rise of pets in Australian households. As a result, the escalating number of pet owners fuels the growth of the veterinary active pharmaceutical ingredients manufacturing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp

What Are the Key Trends Driving Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth?
Emphasizing product innovation is a noticeable trend that is thriving in the veterinary active pharmaceutical ingredient manufacturing industry. The major contenders in this market are making strides towards the creation of novel goods as a strategy to uphold their influence in the market. A case in point, Zoetis Inc., a firm based in the US specializing in veterinary drugs for livestock and pets, confirmed in January 2022 that it had received approval from the US FDA for Solensia (frunevetmab injection), a medication used to manage osteoarthritis (OA) pain in cats. Notably, Solensia is the sole approved feline OA pain injectable monoclonal antibody treatment in the United States. Its efficacy is due to its function, which involves the targeting and inhibition of nerve growth factor (NGF), a primary contributor to pain in cases of osteoarthritis.

How Is the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Segmented?
The veterinary active pharmaceutical ingredients manufacturing market covered in this report is segmented -

1) By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs
2) By Service Type: In House, Contract Outsourcing
3) By Synthesis Type: Chemical Based API, Biological API, Highly Potent API

Subsegments:
1) By Antiparasitic: Endectocides, Anthelmintics, Antiprotozoals
2) By Anti-Infectives: Antibiotics, Antifungals, Antivirals
3) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines
4) By NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Non-Selective NSAIDs, COX-2 Inhibitors

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7942&type=smp

Which Companies Are Leading the Charge in Veterinary Active Pharmaceutical Ingredients Manufacturing Market Innovation?
Major companies operating in the veterinary active pharmaceutical ingredients manufacturing market are Alivira Animal Health Limited, Excel Industries Limited, Ofichem Group B.V., Jiangsu Lingyun Pharmaceutical Co. Ltd., SUANFARMA S.A., NGL Fine-Chem Limited, FIS - Fabbrica Italiana Sintetici S.p.A., Lupin Limited, Aurobindo Pharma Limited, Saneca Pharmaceuticals AS, Neuland Laboratories Limited, Divi's Laboratories Limited, Zoetis Inc., Grupo Indukern S.L., Sequent Scientific Limited, Chempro Pharma Private Limited, AMGIS Lifescience Ltd., Huvepharma AD, Vetpharma Animal Health S.L., Qilu Pharma Spain S.A., INDUKERN Chemie AG, Chemopharma S.A., Norbrook Laboratories Limited, Ceva Santé Animale S.A., Vetoquinol S.A., Virbac S.A.

Which Regions Are Leading the Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market in Revenue?
North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2024. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7942

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.